Benitec Biopharma has an EPS of $-240.04. In 2022, the company made an earnings per share (EPS) of $-643.96. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$240.04 | -62.72% |
2022 | -$643.96 | 1072.76% |
2021 | -$54.91 | -60.12% |
2020 | -$137.70 | - |